MASTL inhibition promotes mitotic catastrophe through PP2A activation to inhibit cancer growth and radioresistance in breast cancer cells

Overview of attention for article published in BMC Cancer, July 2018

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (51st percentile)
Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 28 Dimensions

Readers on

mendeley: 39 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

Pharmaceutical Composition For Preventing or Treating Cancer Targeting MASTL-PP2A

Application KR-20230005714-A

Republic of Korea

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.